279 related articles for article (PubMed ID: 21559817)
1. Update on hormonal contraception and bone density.
Isley MM; Kaunitz AM
Rev Endocr Metab Disord; 2011 Jun; 12(2):93-106. PubMed ID: 21559817
[TBL] [Abstract][Full Text] [Related]
2. Hormonal contraception and bone metabolism: a systematic review.
Nappi C; Bifulco G; Tommaselli GA; Gargano V; Di Carlo C
Contraception; 2012 Dec; 86(6):606-21. PubMed ID: 22717184
[TBL] [Abstract][Full Text] [Related]
3. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
Kaunitz AM
Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
[TBL] [Abstract][Full Text] [Related]
4. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
5. Steroidal contraceptives: effect on bone fractures in women.
Lopez LM; Grimes DA; Schulz KF; Curtis KM
Cochrane Database Syst Rev; 2009 Apr; (2):CD006033. PubMed ID: 19370623
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
Cromer BA; Bonny AE; Stager M; Lazebnik R; Rome E; Ziegler J; Camlin-Shingler K; Secic M
Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
[TBL] [Abstract][Full Text] [Related]
8. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
9. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.
Kaunitz AM; Arias R; McClung M
Contraception; 2008 Feb; 77(2):67-76. PubMed ID: 18226668
[TBL] [Abstract][Full Text] [Related]
10. Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.
Lanza LL; McQuay LJ; Rothman KJ; Bone HG; Kaunitz AM; Harel Z; Ataher Q; Ross D; Arena PL; Wolter KD
Obstet Gynecol; 2013 Mar; 121(3):593-600. PubMed ID: 23635623
[TBL] [Abstract][Full Text] [Related]
11. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
12. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Naessen T; Olsson SE; Gudmundson J
Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
[TBL] [Abstract][Full Text] [Related]
13. The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
Kyvernitakis I; Kostev K; Nassour T; Thomasius F; Hadji P
Osteoporos Int; 2017 Jan; 28(1):291-297. PubMed ID: 27461017
[TBL] [Abstract][Full Text] [Related]
14. Steroidal contraceptives: effect on bone fractures in women.
Lopez LM; Grimes DA; Schulz KF; Curtis KM
Cochrane Database Syst Rev; 2011 Jul; (7):CD006033. PubMed ID: 21735401
[TBL] [Abstract][Full Text] [Related]
15. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
[TBL] [Abstract][Full Text] [Related]
16. Steroidal contraceptives: effect on bone fractures in women.
Lopez LM; Grimes DA; Schulz KF; Curtis KM
Cochrane Database Syst Rev; 2006 Oct; (4):CD006033. PubMed ID: 17054270
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
18. Progestogen-only contraception and bone mineral density: a systematic review.
Curtis KM; Martins SL
Contraception; 2006 May; 73(5):470-87. PubMed ID: 16627031
[TBL] [Abstract][Full Text] [Related]
19. Bone loss associated with long-term use of depot medroxyprogesterone acetate.
Lo SS; Fan SY;
Hong Kong Med J; 2005 Dec; 11(6):491-5. PubMed ID: 16340026
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
